Henoch-Schönlein Disease

Schönlein-Henchob disease (SHD) is a rare microvascular disease with recurrent hemorrhagic syndrome and skin lesions.

The disease was first described in 1882 by German doctors Schonlein and Henoch. It is characterized by damage to small vessels of the skin, mucous membranes and internal organs, which manifests itself in the form of hemorrhages, swelling, pain and other symptoms.

The reasons for the development of GBS are still unclear. It is assumed that it may be associated with genetic factors, infectious diseases, allergic reactions and other factors.

Treatment for GBS depends on its form and severity. It usually involves taking medications such as anticoagulants, immunosuppressants, and others. Physiotherapeutic treatments such as ultrasound, magnetic therapy and others can also be used.

The prognosis for GBS is usually favorable, but some patients may experience complications such as thrombosis and other vascular diseases. Therefore, it is important to consult a doctor promptly and begin treatment.

Henoch-Schönlein disease (HSD) is a rare pathological condition of the microvasculature, characterized by thrombosis, leukohyaline infiltration and proliferation of the walls, the formation of aneurysms, the presence of hematomas, as well as secondary fibrinoid necrosis, autoimmune inflammation and systemic hyperprothrombinemia. The disease debuts with signs of hemorrhagic vasculitis with urinary syndrome and damage to the skin and other organs, including the kidneys, lungs and joints. A characteristic feature of this disease is damage to small vessels along the gastrointestinal tract and skin. The disease is characterized by a polymorphism of clinical manifestations leading to a more severe course, frequent chronic relapsing course, intravascular coagulation and a high incidence of complications.